AOD-9604 Regulatory Status As of June 2026, AOD-9604 is not FDA-approved for any therapeutic use
Excessive doses can leads to potential risks such as inhibition of breast milk production
Important Note This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment
Always consult a qualified healthcare professional before beginning any treatment program
It is a well-characterized, mechanistically specific peptide with a 30-year research history, a strong clinical safety record from formal trials, and modest but real efficacy data from 12-week studies
Any doses, schedules, or combinations shown are examples of what has been reported, not instructions for you